Sep 29, 2016 11:30 am UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 29, 2016 -- Cytokinetics, Inc. (Nasdaq:CYTK) today announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust...
Sep 29, 2016 11:30 am UTC| Business
- Trial achieves primary endpoint - - Dose confirmed for subsequent trials - - Phase 3 expected to start in 2H 2017 - - Company to host conference call at9 a.m. ET today - CAMBRIDGE, Mass., Sept. 29, 2016 --...
Stein Mart Announces CEO Change
Sep 29, 2016 11:30 am UTC| Business
JACKSONVILLE, Fla., Sept. 29, 2016 -- Stein Mart, Inc. (NASDAQ:SMRT) (the “Company”) today announced that Dawn Robertson has tendered her resignation as Chief Executive Officer and as a director, and the Company’s Board...
Sep 29, 2016 11:05 am UTC| Business
SAN RAMON, Calif., Sept. 29, 2016 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet...
Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy
Sep 29, 2016 11:05 am UTC| Business
SALT LAKE CITY, Sept. 29, 2016 -- Myriad Genetics, Inc. (NASDAQ:MYGN) announced today that Chip Parkinson will join the company in the newly created position of executive vice president (EVP) for Reimbursement Strategy....
TESARO and Zai Lab Announce Collaboration, Development and License Agreement
Sep 29, 2016 11:01 am UTC| Business
Collaboration enables the clinical development of niraparib in China by Zai Lab TESARO retains right to co-market in China and receives option to license up to two novel immuno-oncology programs outside ChinaWALTHAM,...
Collegium Announces Publication of Data on Oral Abuse Potential of Xtampza ER
Sep 29, 2016 11:00 am UTC| Business
CANTON, Mass., Sept. 29, 2016 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the publication of “Oral Human Abuse Potential of Oxycodone DETERx® (Xtampza® ER),” in the peer-reviewed medical journal, The...